incidence FR940405-1-00075 1 31
data FR940405-1-00075 4 32 83 505 548
were FR940405-1-00075 4 33 42 88 333
not FR940405-1-00075 4 34 241 412 532
available FR940405-1-00075 1 35
for FR940405-1-00075 5 36 49 122 356 477
nonsmokers FR940405-1-00075 3 37 199 368
, FR940405-1-00075 18 38 62 108 115 138 189 197 266 283 313 330 336 342 364 461 512 516 552
several FR940405-1-00075 2 39 269
survey FR940405-1-00075 5 40 69 114 161 250
sources FR940405-1-00075 3 41 270 549
used FR940405-1-00075 1 43
to FR940405-1-00075 9 44 130 260 272 360 371 428 527 565
estimate FR940405-1-00075 1 45
the FR940405-1-00075 25 46 72 85 91 104 112 119 147 157 184 224 274 284 310 338 398 409 433 457 483 486 504 510 547 556
mortality FR940405-1-00075 1 47
rates FR940405-1-00075 1 48
heart FR940405-1-00075 1 50
disease FR940405-1-00075 2 51 291
( FR940405-1-00075 7 52 66 133 180 293 519 535
framingham FR940405-1-00075 1 53
community FR940405-1-00075 1 54
study FR940405-1-00075 1 55
) FR940405-1-00075 7 56 76 143 188 295 524 538
[ FR940405-1-00075 9 57 77 96 168 201 251 322 494 539
ex FR940405-1-00075 8 58 78 97 169 252 323 495 540
. FR940405-1-00075 24 59 79 82 98 101 144 170 173 200 213 253 256 271 324 327 351 383 420 493 496 499 541 544 575
4108 FR940405-1-00075 1 60
] FR940405-1-00075 9 61 81 100 172 214 255 326 498 543
and FR940405-1-00075 7 63 162 290 358 408 531 573
lung FR940405-1-00075 1 64
cancer FR940405-1-00075 3 65 67 74
prevention FR940405-1-00075 2 68 292
conducted FR940405-1-00075 1 70
by FR940405-1-00075 8 71 111 125 194 227 435 475 489
american FR940405-1-00075 1 73
society FR940405-1-00075 1 75
47 FR940405-1-00075 1 80
on FR940405-1-00075 7 84 103 146 300 353 405 546
us FR940405-1-00075 5 86 120 185 279 311
workforce FR940405-1-00075 2 87 121
obtained FR940405-1-00075 2 89 155
from FR940405-1-00075 3 90 156 305
bureau FR940405-1-00075 1 92
of FR940405-1-00075 15 93 149 183 220 263 276 309 320 367 393 395 426 503 522 558
labor FR940405-1-00075 3 94 186 243
statistics FR940405-1-00075 1 95
439 FR940405-1-00075 1 99
based FR940405-1-00075 4 102 352 403 545
1993 FR940405-1-00075 1 105
annual FR940405-1-00075 1 106
averages FR940405-1-00075 1 107
as FR940405-1-00075 2 109 378
estimated FR940405-1-00075 3 110 129 176
household FR940405-1-00075 1 113
bls FR940405-1-00075 1 116
reports FR940405-1-00075 1 117
that FR940405-1-00075 5 118 177 386 508 555
sectors FR940405-1-00075 2 123 192
covered FR940405-1-00075 2 124 193
this FR940405-1-00075 3 126 195 211
standard FR940405-1-00075 2 127 196
is FR940405-1-00075 5 128 163 175 208 402
be FR940405-1-00075 2 131 390
101631300 FR940405-1-00075 1 132
men FR940405-1-00075 1 134
: FR940405-1-00075 4 135 140 204 454
54.36 FR940405-1-00075 1 136
% FR940405-1-00075 3 137 142 182
women FR940405-1-00075 1 139
45.64 FR940405-1-00075 1 141
information FR940405-1-00075 3 145 299 407
proportion FR940405-1-00075 1 148
employed FR940405-1-00075 6 150 190 222 235 331 514
adults FR940405-1-00075 4 151 179 221 280
who FR940405-1-00075 2 152 561
smoke FR940405-1-00075 2 153 372
was FR940405-1-00075 4 154 411 453 485
national FR940405-1-00075 3 158 285 362
health FR940405-1-00075 3 159 248 286
interview FR940405-1-00075 3 160 249 287
found FR940405-1-00075 1 164
in FR940405-1-00075 15 165 191 210 223 242 257 328 346 373 380 397 415 432 465 482
table FR940405-1-00075 6 166 206 215 381 421 536
iv7 FR940405-1-00075 1 167
4235 FR940405-1-00075 1 171
it FR940405-1-00075 2 174 401
74201000 FR940405-1-00075 1 178
73.01 FR940405-1-00075 2 181 237
force FR940405-1-00075 2 187 244
are FR940405-1-00075 2 198 562
editorial FR940405-1-00075 1 202
note FR940405-1-00075 1 203
no FR940405-1-00075 2 205 445
iv6 FR940405-1-00075 1 207
included FR940405-1-00075 1 209
preamble FR940405-1-00075 1 212
iv FR940405-1-00075 2 216 422
7._ FR940405-1-00075 1 217
percent FR940405-1-00075 6 218 366 388 424 518 557
estimates FR940405-1-00075 3 219 363 425
united FR940405-1-00075 1 225
states FR940405-1-00075 1 226
smoking FR940405-1-00075 4 228 277 301 436
status FR940405-1-00075 2 229 437
1 FR940405-1-00075 4 230 231 438 439
1smoker FR940405-1-00075 2 232 440
1nonsmoker FR940405-1-00075 2 233 441
currently FR940405-1-00075 2 234 513
26.99 FR940405-1-00075 1 236
unemployed FR940405-1-00075 1 238
40.38 FR940405-1-00075 1 239
59.62 FR940405-1-00075 1 240
21.50 FR940405-1-00075 1 245
78.50 FR940405-1-00075 1 246
1national FR940405-1-00075 1 247
235 FR940405-1-00075 1 254
an FR940405-1-00075 2 258 391
effort FR940405-1-00075 1 259
characterize FR940405-1-00075 1 261
prevalence FR940405-1-00075 2 262 275
occupational FR940405-1-00075 1 264
exposure FR940405-1-00075 6 265 302 370 396 481 526
osha FR940405-1-00075 4 267 384 476 553
considered FR940405-1-00075 2 268 474
determine FR940405-1-00075 1 273
among FR940405-1-00075 2 278 509
during FR940405-1-00075 3 281 337 456
1991 FR940405-1-00075 1 282
surveyhealth FR940405-1-00075 1 288
promotion FR940405-1-00075 1 289
nhishpdp FR940405-1-00075 1 294
supplement FR940405-1-00075 1 296
collected FR940405-1-00075 1 297
selfreported FR940405-1-00075 2 298 406
at FR940405-1-00075 4 303 529 533 567
work FR940405-1-00075 7 304 349 376 418 468 487 530
a FR940405-1-00075 3 306 431 500
representative FR940405-1-00075 1 307
sample FR940405-1-00075 1 308
civilian FR940405-1-00075 1 312
nond FR940405-1-00075 1 314
population FR940405-1-00075 1 315
greater FR940405-1-00075 1 316
than FR940405-1-00075 1 317
18 FR940405-1-00075 1 318
years FR940405-1-00075 1 319
age FR940405-1-00075 1 321
451 FR940405-1-00075 1 325
particular FR940405-1-00075 1 329
individuals FR940405-1-00075 1 332
asked FR940405-1-00075 1 334
whether FR940405-1-00075 1 335
past FR940405-1-00075 2 339 458
two FR940405-1-00075 1 340
weeks FR940405-1-00075 2 341 460
anyone FR940405-1-00075 2 343 463
had FR940405-1-00075 1 344
smoked FR940405-1-00075 2 345 464
their FR940405-1-00075 3 347 374 568
immediate FR940405-1-00075 4 348 375 417 467
area FR940405-1-00075 4 350 377 419 469
results FR940405-1-00075 1 354
adjusted FR940405-1-00075 1 355
nonresponse FR940405-1-00075 1 357
weighted FR940405-1-00075 1 359
reflect FR940405-1-00075 1 361
18.81 FR940405-1-00075 4 365 387 444 572
reported FR940405-1-00075 2 369 525
shown FR940405-1-00075 1 379
iv8 FR940405-1-00075 1 382
believes FR940405-1-00075 1 385
may FR940405-1-00075 1 389
underestimate FR940405-1-00075 1 392
frequency FR940405-1-00075 1 394
workplace FR940405-1-00075 2 399 484
because FR940405-1-00075 1 400
solely FR940405-1-00075 1 404
question FR940405-1-00075 2 410 429
very FR940405-1-00075 1 413
specific FR940405-1-00075 1 414
defining FR940405-1-00075 2 416 478
8._ FR940405-1-00075 1 423
responses FR940405-1-00075 1 427
6 FR940405-1-00075 1 430
nhis FR940405-1-00075 1 434
yes FR940405-1-00075 1 442
37.58 FR940405-1-00075 1 443
60.81 FR940405-1-00075 1 446
79.79 FR940405-1-00075 1 447
unknown FR940405-1-00075 1 448
1.61 FR940405-1-00075 1 449
1.39 FR940405-1-00075 1 450
1question FR940405-1-00075 1 451
6a FR940405-1-00075 1 452
`` FR940405-1-00075 1 455
2 FR940405-1-00075 1 459
has FR940405-1-00075 1 462
your FR940405-1-00075 1 466
? FR940405-1-00075 1 470
'' FR940405-1-00075 1 471
another FR940405-1-00075 1 472
source FR940405-1-00075 1 473
nonsmoker FR940405-1-00075 1 479
ets FR940405-1-00075 3 480 528 566
published FR940405-1-00075 1 488
cummings FR940405-1-00075 1 490
et FR940405-1-00075 1 491
al FR940405-1-00075 1 492
467 FR940405-1-00075 1 497
recent FR940405-1-00075 1 501
res FR940405-1-00075 1 502
file FR940405-1-00075 1 506
showed FR940405-1-00075 1 507
nonsmoking FR940405-1-00075 2 511 559
subjects FR940405-1-00075 1 515
48.67 FR940405-1-00075 2 517 574
165 FR940405-1-00075 1 520
out FR940405-1-00075 1 521
339 FR940405-1-00075 1 523
home FR940405-1-00075 1 534
iv9 FR940405-1-00075 1 537
469 FR940405-1-00075 1 542
mentioned FR940405-1-00075 1 550
above FR940405-1-00075 1 551
assumes FR940405-1-00075 1 554
workers FR940405-1-00075 1 560
potentially FR940405-1-00075 1 563
exposed FR940405-1-00075 1 564
worksite FR940405-1-00075 1 569
ranges FR940405-1-00075 1 570
between FR940405-1-00075 1 571
table FR940405-1-00076 4 0 788 897 903
iv FR940405-1-00076 1 1
9._ FR940405-1-00076 1 2
prevalence FR940405-1-00076 1 3
of FR940405-1-00076 41 4 62 69 87 147 158 170 188 200 212 228 254 287 300 314 371 382 423 435 452 480 517 533 542 560 597 678 741 756 771 780 816 829 851 888 943 959 964 969 975 1001
ets FR940405-1-00076 11 5 101 138 429 440 565 763 799 893 913 936
exposure FR940405-1-00076 12 6 66 74 465 735 749 761 797 841 971 989 1002
for FR940405-1-00076 20 7 184 257 275 284 303 318 327 335 425 458 484 499 503 595 602 636 848 882 907
nonsmoking FR940405-1-00076 15 8 94 133 152 159 189 229 258 268 276 436 561 689 704 781
workers1 FR940405-1-00076 1 9
1subject FR940405-1-00076 1 10
category FR940405-1-00076 1 11
1count FR940405-1-00076 1 12
1percent FR940405-1-00076 1 13
exposed FR940405-1-00076 12 14 21 30 40 99 134 427 438 563 802 911 934
at FR940405-1-00076 10 15 22 26 31 35 41 442 567 937 960
work FR940405-1-00076 6 16 27 32 42 443 568
and FR940405-1-00076 13 17 350 501 592 663 675 691 713 738 923 972 991 999
home FR940405-1-00076 4 18 23 36 44
99 FR940405-1-00076 1 19
29.22 FR940405-1-00076 1 20
, FR940405-1-00076 22 24 33 89 92 214 216 220 291 356 489 506 616 631 634 646 662 669 726 731 856 914 945
not FR940405-1-00076 3 25 34 39
23 FR940405-1-00076 1 28
6.78 FR940405-1-00076 1 29
165 FR940405-1-00076 1 37
48.67 FR940405-1-00076 2 38 580
or FR940405-1-00076 3 43 831 879
52 FR940405-1-00076 1 45
15.34 FR940405-1-00076 1 46
1data FR940405-1-00076 1 47
source FR940405-1-00076 1 48
: FR940405-1-00076 6 49 83 105 126 397 416
cummings FR940405-1-00076 1 50
reanalysis FR940405-1-00076 1 51
[ FR940405-1-00076 4 52 404 473 519
ex FR940405-1-00076 3 53 474 520
. FR940405-1-00076 33 54 57 225 248 270 283 305 321 363 378 444 472 475 478 496 521 524 557 584 605 628 642 680 695 723 752 787 804 885 899 948 981 1009
469 FR940405-1-00076 1 55
] FR940405-1-00076 4 56 414 477 523
d. FR940405-1-00076 1 58
osha FR940405-1-00076 5 59 292 445 585 857
's FR940405-1-00076 3 60 721 988
estimates FR940405-1-00076 5 61 479 596 887 956
risk_environmental FR940405-1-00076 1 63
tobacco FR940405-1-00076 1 64
smoke FR940405-1-00076 1 65
the FR940405-1-00076 57 67 80 84 130 144 156 162 167 173 179 186 198 210 226 249 271 285 296 315 322 360 379 389 395 419 433 525 534 539 543 558 590 598 611 625 643 651 681 702 719 728 747 753 768 778 784 791 817 843 849 860 870 941 949 957 986 997
incidence FR940405-1-00076 8 68 168 182 252 274 298 325 380
disease FR940405-1-00076 10 70 171 232 332 383 424 486 757 930 965
due FR940405-1-00076 1 71
to FR940405-1-00076 30 72 100 137 206 262 280 339 343 428 439 564 575 579 587 624 638 673 687 746 759 762 795 798 842 891 912 925 935 952 979
occupational FR940405-1-00076 6 73 464 734 760 796 892
in FR940405-1-00076 19 75 93 132 151 161 311 366 487 509 610 650 724 727 783 877 896 902 940 966
nonsmokers FR940405-1-00076 8 76 185 208 304 336 426 462 488
was FR940405-1-00076 12 77 194 239 529 573 648 656 670 706 736 750 764
estimated FR940405-1-00076 8 78 145 195 240 279 342 393 765
using FR940405-1-00076 3 79 394 538
following FR940405-1-00076 1 81
methodology FR940405-1-00076 1 82
expected FR940405-1-00076 2 85 769
number FR940405-1-00076 8 86 146 157 187 211 227 770 779
cases FR940405-1-00076 4 88 131 148 772
n FR940405-1-00076 11 90 106 111 116 127 141 154 192 236 242 774
e FR940405-1-00076 8 91 107 128 408 412 431 571 775
workers FR940405-1-00076 13 95 135 153 160 175 190 230 320 391 437 562 782 910
who FR940405-1-00076 2 96 204
are FR940405-1-00076 4 97 614 894 933
occupationally FR940405-1-00076 1 98
is FR940405-1-00076 13 102 129 143 155 166 178 260 278 341 392 418 432 875
expressed FR940405-1-00076 1 103
by FR940405-1-00076 11 104 196 209 223 359 468 492 632 708 766 777
=n FR940405-1-00076 2 108 244
d FR940405-1-00076 4 109 142 237 243
^ FR940405-1-00076 2 110 121
* FR940405-1-00076 4 112 117 245 406
i FR940405-1-00076 9 113 119 122 164 176 246 385 398 401
u FR940405-1-00076 5 114 123 165 386 399
= FR940405-1-00076 3 115 400 554
( FR940405-1-00076 14 118 191 235 384 410 455 497 548 549 569 773 807 810 813
p FR940405-1-00076 7 120 177 247 402 407 430 570
) FR940405-1-00076 14 124 193 238 387 413 457 505 553 556 572 776 809 812 815
where FR940405-1-00076 2 125 415
attributable FR940405-1-00076 7 136 745 758 794 861 866 890
per FR940405-1-00076 8 139 149 233 265 346 352 374 800
year FR940405-1-00076 5 140 150 234 978 980
us FR940405-1-00076 6 163 180 250 544 612 785
rate FR940405-1-00076 6 169 183 253 299 326 381
among FR940405-1-00076 3 172 388 461
unexposed FR940405-1-00076 2 174 390
population FR940405-1-00076 5 181 219 251 297 786
multiplying FR940405-1-00076 1 197
percent FR940405-1-00076 1 199
currently FR940405-1-00076 1 201
employed FR940405-1-00076 3 202 215 876
adults FR940405-1-00076 1 203
report FR940405-1-00076 1 205
be FR940405-1-00076 5 207 263 281 344 622
adult FR940405-1-00076 1 213
civilian FR940405-1-00076 1 217
noninstitutional FR940405-1-00076 1 218
as FR940405-1-00076 9 221 241 295 357 448 466 490 546 581
reported FR940405-1-00076 6 222 261 358 467 491 535
bls FR940405-1-00076 1 224
with FR940405-1-00076 4 231 463 718 846
lung FR940405-1-00076 6 255 272 301 459 742 921
cancer FR940405-1-00076 6 256 273 302 460 743 922
women FR940405-1-00076 3 259 269 355
0.121 FR940405-1-00076 2 264 294
one FR940405-1-00076 5 266 347 353 375 962
thousand FR940405-1-00076 4 267 348 354 376
males FR940405-1-00076 2 277 504
higher FR940405-1-00076 1 282
purpose FR940405-1-00076 1 286
this FR940405-1-00076 3 288 306 364
risk FR940405-1-00076 14 289 317 422 454 483 515 528 744 755 793 863 868 889 955
assessment FR940405-1-00076 2 290 722
used FR940405-1-00076 5 293 446 508 684 951
will FR940405-1-00076 3 307 917 927
most FR940405-1-00076 2 308 918
likely FR940405-1-00076 2 309 919
result FR940405-1-00076 1 310
an FR940405-1-00076 7 312 367 449 511 739 837 865
underestimate FR940405-1-00076 1 313
true FR940405-1-00076 1 316
male FR940405-1-00076 1 319
average FR940405-1-00076 3 323 370 532
annual FR940405-1-00076 4 324 754 792 862
death FR940405-1-00076 1 328
from FR940405-1-00076 3 329 577 977
coronary FR940405-1-00076 1 330
heart FR940405-1-00076 3 331 485 929
excluding FR940405-1-00076 1 333
strokes FR940405-1-00076 1 334
age FR940405-1-00076 1 337
35 FR940405-1-00076 1 338
64 FR940405-1-00076 1 340
4 FR940405-1-00076 1 345
men FR940405-1-00076 1 349
2 FR940405-1-00076 1 351
framingham FR940405-1-00076 1 361
study FR940405-1-00076 6 362 645 668 683 696 730
results FR940405-1-00076 2 365 620
overall FR940405-1-00076 2 368 512
weighted FR940405-1-00076 2 369 531
3 FR940405-1-00076 1 372
deaths FR940405-1-00076 1 373
individuals FR940405-1-00076 1 377
relationship FR940405-1-00076 1 396
/ FR940405-1-00076 1 403
rr FR940405-1-00076 3 405 417 456
+ FR940405-1-00076 2 409 551
1^p FR940405-1-00076 1 411
observed FR940405-1-00076 4 420 450 481 599
relative FR940405-1-00076 7 421 453 482 514 527 536 600
proportion FR940405-1-00076 2 434 559
while FR940405-1-00076 2 441 566
1.34 FR940405-1-00076 1 447
estimate FR940405-1-00076 3 451 516 740
fontham FR940405-1-00076 4 469 591 682 729
et FR940405-1-00076 2 470 494
al FR940405-1-00076 2 471 495
4106 FR940405-1-00076 1 476
helsing FR940405-1-00076 3 493 593 644
1.24 FR940405-1-00076 1 498
females FR940405-1-00076 1 500
1.31 FR940405-1-00076 1 502
were FR940405-1-00076 4 507 608 698 716
calculating FR940405-1-00076 1 510
adjusted FR940405-1-00076 2 513 526
1.28 FR940405-1-00076 2 518 555
4139 FR940405-1-00076 1 522
a FR940405-1-00076 6 530 639 665 873 944 1006
risks FR940405-1-00076 2 537 601
gender FR940405-1-00076 1 540
composition FR940405-1-00076 1 541
workforce FR940405-1-00076 1 545
weights FR940405-1-00076 1 547
1.24*45.64 FR940405-1-00076 1 550
1.31*54.36/100 FR940405-1-00076 1 552
assumed FR940405-1-00076 1 574
range FR940405-1-00076 1 576
18.81 FR940405-1-00076 1 578
stated FR940405-1-00076 1 582
previously FR940405-1-00076 1 583
chose FR940405-1-00076 1 586
rely FR940405-1-00076 1 588
on FR940405-1-00076 3 589 733 869
studies FR940405-1-00076 4 594 607 618 630
several FR940405-1-00076 1 603
reasons FR940405-1-00076 1 604
both FR940405-1-00076 3 606 613 629
conducted FR940405-1-00076 1 609
large FR940405-1-00076 2 615 640
populationbased FR940405-1-00076 1 617
whose FR940405-1-00076 1 619
can FR940405-1-00076 1 621
generalized FR940405-1-00076 1 623
general FR940405-1-00076 1 626
public FR940405-1-00076 1 627
design FR940405-1-00076 1 633
controlled FR940405-1-00076 1 635
misclassification FR940405-1-00076 2 637 674
degree FR940405-1-00076 1 641
which FR940405-1-00076 1 647
done FR940405-1-00076 1 649
60's_a FR940405-1-00076 1 652
time FR940405-1-00076 1 653
when FR940405-1-00076 1 654
smoking FR940405-1-00076 1 655
more FR940405-1-00076 2 657 660
acceptable FR940405-1-00076 1 658
than FR940405-1-00076 1 659
recently FR940405-1-00076 1 661
being FR940405-1-00076 1 664
prospective FR940405-1-00076 1 666
cohort FR940405-1-00076 1 667
less FR940405-1-00076 1 671
prone FR940405-1-00076 1 672
other FR940405-1-00076 1 676
sources FR940405-1-00076 2 677 686
bias FR940405-1-00076 1 679
multiple FR940405-1-00076 1 685
ascertain FR940405-1-00076 1 688
status FR940405-1-00076 2 690 705
validate FR940405-1-00076 1 692
subject FR940405-1-00076 1 693
response FR940405-1-00076 1 694
subjects FR940405-1-00076 1 697
questioned FR940405-1-00076 1 699
twice FR940405-1-00076 1 700
; FR940405-1-00076 2 701 712
selfreported FR940405-1-00076 1 703
corroborated FR940405-1-00076 1 707
urinary FR940405-1-00076 1 709
cotinine FR940405-1-00076 1 710
measurements FR940405-1-00076 1 711
medical FR940405-1-00076 1 714
records FR940405-1-00076 1 715
crossreferenced FR940405-1-00076 1 717
physician FR940405-1-00076 1 720
addition FR940405-1-00076 1 725
information FR940405-1-00076 2 732 900
collected FR940405-1-00076 1 737
workplace FR940405-1-00076 2 748 939
ascertained FR940405-1-00076 1 751
dividing FR940405-1-00076 1 767
iv10 FR940405-1-00076 3 789 898 904
presents FR940405-1-00076 1 790
1000 FR940405-1-00076 2 801 909
employees FR940405-1-00076 1 803
because FR940405-1-00076 1 805
section FR940405-1-00076 1 806
6 FR940405-1-00076 1 808
b FR940405-1-00076 1 811
5 FR940405-1-00076 1 814
osh FR940405-1-00076 1 818
act FR940405-1-00076 1 819
states FR940405-1-00076 1 820
that FR940405-1-00076 5 821 872 906 985 994
no FR940405-1-00076 1 822
employee FR940405-1-00076 2 823 838
shall FR940405-1-00076 1 824
suffer FR940405-1-00076 1 825
`` FR940405-1-00076 1 826
material FR940405-1-00076 1 827
impairment FR940405-1-00076 1 828
health FR940405-1-00076 1 830
functional FR940405-1-00076 1 832
capacity FR940405-1-00076 1 833
even FR940405-1-00076 1 834
if FR940405-1-00076 2 835 931
such FR940405-1-00076 1 836
has FR940405-1-00076 2 839 858
regular FR940405-1-00076 1 840
hazard FR940405-1-00076 1 844
dealt FR940405-1-00076 1 845
*** FR940405-1-00076 1 847
period FR940405-1-00076 1 850
his FR940405-1-00076 2 852 878
working FR940405-1-00076 4 853 946 992 1007
life FR940405-1-00076 1 854
'' FR940405-1-00076 1 855
converted FR940405-1-00076 1 859
into FR940405-1-00076 1 864
lifetime FR940405-1-00076 5 867 886 947 954 1008
assumption FR940405-1-00076 1 871
worker FR940405-1-00076 2 874 987
her FR940405-1-00076 1 880
occupation FR940405-1-00076 1 881
45 FR940405-1-00076 2 883 967
years FR940405-1-00076 2 884 968
presented FR940405-1-00076 1 895
contained FR940405-1-00076 1 901
indicates FR940405-1-00076 1 905
every FR940405-1-00076 1 908
approximately FR940405-1-00076 1 915
1 FR940405-1-00076 1 916
develop FR940405-1-00076 2 920 928
7 FR940405-1-00076 1 924
16 FR940405-1-00076 1 926
they FR940405-1-00076 1 932
their FR940405-1-00076 1 938
course FR940405-1-00076 1 942
formula FR940405-1-00076 1 950
calculate FR940405-1-00076 1 953
probability FR940405-1-00076 1 958
least FR940405-1-00076 1 961
occurrence FR940405-1-00076 1 963
continuous FR940405-1-00076 1 970
assumes FR940405-1-00076 2 973 984
independence FR940405-1-00076 1 974
events FR940405-1-00076 1 976
it FR940405-1-00076 1 982
also FR940405-1-00076 1 983
profile FR940405-1-00076 1 990
conditions FR940405-1-00076 1 993
may FR940405-1-00076 1 995
affect FR940405-1-00076 1 996
level FR940405-1-00076 1 998
intensity FR940405-1-00076 1 1000
remain FR940405-1-00076 1 1003
constant FR940405-1-00076 1 1004
throughout FR940405-1-00076 1 1005
table FR940405-1-00077 3 0 844 1112
iv FR940405-1-00077 1 1
10._ FR940405-1-00077 1 2
estimates FR940405-1-00077 5 3 840 975 1105 1214
of FR940405-1-00077 36 4 35 54 72 146 197 236 320 341 360 363 377 397 403 409 415 430 439 473 495 537 550 599 601 631 700 718 723 760 772 838 1029 1122 1130 1181 1208
risk FR940405-1-00077 15 5 41 45 90 95 594 629 689 920 963 1088 1104 1133 1188 1213
for FR940405-1-00077 22 6 46 286 400 640 653 658 686 704 730 830 866 901 921 929 964 989 1009 1070 1089 1106 1185
nonsmoking FR940405-1-00077 3 7 47 55
workers FR940405-1-00077 6 8 39 48 56 200 824
exposed FR940405-1-00077 4 9 57 1083 1099
to FR940405-1-00077 28 10 58 66 129 213 226 246 259 270 272 337 356 372 500 510 520 590 608 625 768 850 913 926 954 1126 1170 1193 1216
ets FR940405-1-00077 3 11 59 641
at FR940405-1-00077 5 12 40 60 1001 1014
the FR940405-1-00077 54 13 52 61 88 153 156 164 184 208 240 254 267 293 311 315 342 358 413 416 420 428 471 523 535 572 575 597 604 643 649 665 694 716 748 770 794 820 855 918 948 972 977 986 1007 1027 1033 1050 1054 1066 1086 1131 1160 1179 1182
workplace FR940405-1-00077 2 14 62
1,2 FR940405-1-00077 1 15
1 FR940405-1-00077 2 16 79
1annual FR940405-1-00077 1 17
risk2 FR940405-1-00077 1 18
1lifetime FR940405-1-00077 1 19
occupational FR940405-1-00077 5 20 73 1132 1187 1217
risk3 FR940405-1-00077 1 21
lung FR940405-1-00077 1 22
cancer FR940405-1-00077 1 23
0.010.02 FR940405-1-00077 1 24
0.41 FR940405-1-00077 1 25
heart FR940405-1-00077 1 26
disease FR940405-1-00077 1 27
0.150.36 FR940405-1-00077 1 28
716 FR940405-1-00077 1 29
1risks FR940405-1-00077 1 30
are FR940405-1-00077 8 31 106 125 136 150 201 841 1109
expressed FR940405-1-00077 1 32
as FR940405-1-00077 16 33 78 108 138 216 258 283 498 637 698 891 911 935 959 1057 1163
number FR940405-1-00077 4 34 396 402 598
cases FR940405-1-00077 2 36 600
per FR940405-1-00077 5 37 1004 1017 1080 1096
1000 FR940405-1-00077 1 38
. FR940405-1-00077 47 42 68 91 121 148 167 173 180 189 206 251 290 314 344 365 381 387 411 466 506 539 564 577 596 642 685 711 726 739 742 753 780 793 819 825 846 896 917 968 1019 1048 1101 1114 1138 1174 1198 1219
2the FR940405-1-00077 1 43
annual FR940405-1-00077 4 44 89 987 1210
is FR940405-1-00077 10 49 76 87 325 1000 1013 1024 1037 1078 1094
estimated FR940405-1-00077 5 50 734 827 1025 1064
assuming FR940405-1-00077 1 51
proportion FR940405-1-00077 3 53 1028 1162
ranges FR940405-1-00077 1 63
from FR940405-1-00077 6 64 140 859 952 976 1119
18.81 FR940405-1-00077 1 65
48.67 FR940405-1-00077 1 67
3assumes FR940405-1-00077 1 69
45 FR940405-1-00077 2 70 83
years FR940405-1-00077 1 71
exposure FR940405-1-00077 1 74
and FR940405-1-00077 24 75 114 158 183 276 383 425 460 485 561 674 676 708 809 813 835 861 865 886 905 1006 1053 1085 1211
calculated FR940405-1-00077 1 77
( FR940405-1-00077 5 80 111 118 542 1040
1p FR940405-1-00077 1 81
) FR940405-1-00077 5 82 113 120 544 1047
, FR940405-1-00077 39 84 134 176 220 231 242 253 292 308 347 423 468 476 478 482 508 513 528 579 668 670 673 691 803 812 875 880 885 933 940 945 947 982 992 999 1022 1062 1140 1201
where FR940405-1-00077 1 85
p FR940405-1-00077 1 86
e. FR940405-1-00077 1 92
osha FR940405-1-00077 14 93 366 580 620 692 712 869 956 1063 1102 1115 1141 1175 1202
's FR940405-1-00077 4 94 744 863 1103
estimates_indoor FR940405-1-00077 1 96
air FR940405-1-00077 10 97 448 454 461 496 504 524 611 1108 1196
quality FR940405-1-00077 3 98 612 1197
adverse FR940405-1-00077 1 99
health FR940405-1-00077 3 100 645 979
effects FR940405-1-00077 1 101
associated FR940405-1-00077 4 102 533 775 1152
with FR940405-1-00077 17 103 203 317 436 450 456 463 492 502 517 534 776 799 806 816 1035 1153
poor FR940405-1-00077 3 104 609 1194
iaq FR940405-1-00077 1 105
described FR940405-1-00077 2 107 1058
buildingrelated FR940405-1-00077 2 109 540
illness FR940405-1-00077 3 110 541 602
bri FR940405-1-00077 3 112 543 587
sick FR940405-1-00077 4 115 249 322 431
building FR940405-1-00077 10 116 157 230 289 313 432 531 576 751 832
syndrome FR940405-1-00077 1 117
sbs FR940405-1-00077 5 119 122 378 518 632
related FR940405-1-00077 5 123 379 588 607 833
conditions FR940405-1-00077 10 124 380 549 707 732 904 932 967 1012 1093
not FR940405-1-00077 4 126 569 582 614
easily FR940405-1-00077 1 127
traced FR940405-1-00077 1 128
a FR940405-1-00077 11 130 221 395 401 514 592 627 634 757 836 1120
single FR940405-1-00077 1 131
specific FR940405-1-00077 2 132 547
substance FR940405-1-00077 1 133
but FR940405-1-00077 1 135
perceived FR940405-1-00077 1 137
resulting FR940405-1-00077 1 139
some FR940405-1-00077 2 141 530
unidentified FR940405-1-00077 1 142
contaminant FR940405-1-00077 1 143
or FR940405-1-00077 6 144 332 527 567 786 996
combination FR940405-1-00077 1 145
contaminants FR940405-1-00077 1 147
symptoms FR940405-1-00077 14 149 205 241 343 364 433 487 565 589 662 774 834 853 895
relieved FR940405-1-00077 1 151
when FR940405-1-00077 2 152 571
employee FR940405-1-00077 2 154 573
leaves FR940405-1-00077 2 155 574
may FR940405-1-00077 3 159 566 568
be FR940405-1-00077 10 160 214 225 244 247 271 273 556 927 1167
reduced FR940405-1-00077 1 161
by FR940405-1-00077 3 162 558 735
modifying FR940405-1-00077 1 163
ventilation FR940405-1-00077 5 165 410 440 808 818
system FR940405-1-00077 2 166 526
research FR940405-1-00077 2 168 352
in FR940405-1-00077 27 169 296 304 310 394 419 434 490 522 529 603 721 765 843 847 908 971 1020 1032 1059 1074 1111 1134 1149 1159 1189 1199
britain FR940405-1-00077 1 170
[ FR940405-1-00077 5 171 178 187 385 737
ex FR940405-1-00077 5 172 179 188 386 738
444 FR940405-1-00077 1 174
] FR940405-1-00077 5 175 182 191 389 741
denmark FR940405-1-00077 1 177
4284 FR940405-1-00077 1 181
united FR940405-1-00077 2 185 605
states FR940405-1-00077 2 186 606
3745 FR940405-1-00077 1 190
indicates FR940405-1-00077 1 192
that FR940405-1-00077 8 193 228 326 350 985 1026 1065 1146
about FR940405-1-00077 1 194
20 FR940405-1-00077 4 195 209 234 264
% FR940405-1-00077 4 196 210 235 265
all FR940405-1-00077 3 198 781 1135
office FR940405-1-00077 7 199 763 778 1030 1076 1124 1156
afflicted FR940405-1-00077 1 202
such FR940405-1-00077 3 204 281 934
if FR940405-1-00077 1 207
level FR940405-1-00077 1 211
were FR940405-1-00077 3 212 733 783
considered FR940405-1-00077 3 215 245 274
`` FR940405-1-00077 11 217 248 321 329 871 876 881 887 936 941 973
background FR940405-1-00077 4 218 339 361 375
'' FR940405-1-00077 11 219 250 323 331 874 879 884 890 939 944 984
simple FR940405-1-00077 1 222
approach FR940405-1-00077 1 223
would FR940405-1-00077 4 224 243 266 278
determine FR940405-1-00077 2 227 338
any FR940405-1-00077 4 229 287 493 584
more FR940405-1-00077 1 232
than FR940405-1-00077 4 233 263 664 683
whose FR940405-1-00077 1 237
occupants FR940405-1-00077 1 238
report FR940405-1-00077 1 239
however FR940405-1-00077 2 252 619
question FR940405-1-00077 1 255
then FR940405-1-00077 1 256
arises FR940405-1-00077 1 257
how FR940405-1-00077 2 260 277
much FR940405-1-00077 1 261
greater FR940405-1-00077 1 262
incidence FR940405-1-00077 3 268 702 724
have FR940405-1-00077 3 269 328 583
excess FR940405-1-00077 2 275 1068
one FR940405-1-00077 4 279 288 1081 1097
address FR940405-1-00077 3 280 357 373
issues FR940405-1-00077 1 282
statistical FR940405-1-00077 1 284
significance FR940405-1-00077 1 285
furthermore FR940405-1-00077 2 291 1139
definition FR940405-1-00077 1 294
used FR940405-1-00077 5 295 336 693 957 1116
assessing FR940405-1-00077 1 297
symptom FR940405-1-00077 3 298 306 391
occurrence FR940405-1-00077 2 299 771
can FR940405-1-00077 3 300 554 1166
cause FR940405-1-00077 1 301
substantial FR940405-1-00077 1 302
variations FR940405-1-00077 1 303
estimating FR940405-1-00077 2 305 1186
prevalence FR940405-1-00077 4 307 340 429 472
even FR940405-1-00077 1 309
same FR940405-1-00077 3 312 1055 1161
problem FR940405-1-00077 2 316 516
many FR940405-1-00077 1 318
investigations FR940405-1-00077 1 319
buildings FR940405-1-00077 19 324 334 404 435 491 501 764 779 782 798 805 815 910 916 1031 1077 1125 1137 1191
rarely FR940405-1-00077 1 327
nonk FR940405-1-00077 1 330
control FR940405-1-00077 1 333
been FR940405-1-00077 3 335 354 616
until FR940405-1-00077 1 345
now FR940405-1-00077 1 346
it FR940405-1-00077 2 348 1023
appears FR940405-1-00077 2 349 519
limited FR940405-1-00077 1 351
has FR940405-1-00077 3 353 613 621
done FR940405-1-00077 2 355 639
issue FR940405-1-00077 1 359
levels FR940405-1-00077 2 362 376
seeks FR940405-1-00077 4 367 713 1176 1203
input FR940405-1-00077 1 368
on FR940405-1-00077 7 369 412 586 679 715 1178 1205
data FR940405-1-00077 7 370 585 651 720 725 745 1117
sources FR940405-1-00077 1 371
expected FR940405-1-00077 1 374
mendell FR940405-1-00077 8 382 424 736 743 826 862 897 1183
smith FR940405-1-00077 2 384 426
4218 FR940405-1-00077 1 388
examined FR940405-1-00077 1 390
reports FR940405-1-00077 2 392 970
compiled FR940405-1-00077 1 393
individual FR940405-1-00077 2 398 421
studies FR940405-1-00077 2 399 422
which FR940405-1-00077 3 405 553 1165
had FR940405-1-00077 2 406 787
different FR940405-1-00077 1 407
types FR940405-1-00077 2 408 438
basis FR940405-1-00077 1 414
information FR940405-1-00077 2 417 1052
gathered FR940405-1-00077 1 418
compared FR940405-1-00077 3 427 499 912
five FR940405-1-00077 1 437
: FR940405-1-00077 1 441
natural FR940405-1-00077 2 442 817
only FR940405-1-00077 2 443 446
; FR940405-1-00077 5 444 447 453 459 618
fans FR940405-1-00077 1 445
conditioned FR940405-1-00077 3 449 455 462
no FR940405-1-00077 3 451 503 810
humidification FR940405-1-00077 3 452 458 465
steam FR940405-1-00077 1 457
waterbased FR940405-1-00077 1 464
overall FR940405-1-00077 1 467
they FR940405-1-00077 1 469
found FR940405-1-00077 1 470
workrelated FR940405-1-00077 3 474 773 1150
headache FR940405-1-00077 1 475
lethargy FR940405-1-00077 1 477
upper FR940405-1-00077 9 479 660 705 892 902 930 965 1010 1091
respiratory/mucous FR940405-1-00077 2 480 893
membrane FR940405-1-00077 2 481 894
lower FR940405-1-00077 1 483
respiratory FR940405-1-00077 8 484 661 706 903 931 966 1011 1092
skin FR940405-1-00077 1 486
significantly FR940405-1-00077 1 488
increased FR940405-1-00077 1 489
type FR940405-1-00077 1 494
conditioning FR940405-1-00077 4 497 505 525 801
thus FR940405-1-00077 1 507
according FR940405-1-00077 1 509
this FR940405-1-00077 3 511 687 754
analysis FR940405-1-00077 2 512 1045
basic FR940405-1-00077 1 515
reside FR940405-1-00077 1 521
aspect FR940405-1-00077 1 532
presence FR940405-1-00077 1 536
airconditioning FR940405-1-00077 3 538 811 1036
describes FR940405-1-00077 1 545
those FR940405-1-00077 1 546
medical FR940405-1-00077 2 548 994
known FR940405-1-00077 1 551
etiology FR940405-1-00077 1 552
often FR940405-1-00077 1 555
documented FR940405-1-00077 1 557
physical FR940405-1-00077 1 559
signs FR940405-1-00077 1 560
laboratory FR940405-1-00077 1 562
findings FR940405-1-00077 1 563
disappear FR940405-1-00077 1 570
currently FR940405-1-00077 1 578
does FR940405-1-00077 1 581
conduct FR940405-1-00077 1 591
quantitative FR940405-1-00077 1 593
assessment FR940405-1-00077 3 595 690 1129
indoor FR940405-1-00077 3 610 1107 1195
yet FR940405-1-00077 1 615
quantified FR940405-1-00077 1 617
made FR940405-1-00077 2 622 1142
an FR940405-1-00077 7 623 848 960 1128 1143 1147 1154
attempt FR940405-1-00077 1 624
develop FR940405-1-00077 1 626
preliminary FR940405-1-00077 3 628 688 1042
estimate FR940405-1-00077 1 630
using FR940405-1-00077 2 633 1049
similar FR940405-1-00077 1 635
methodology FR940405-1-00077 3 636 1056 1207
was FR940405-1-00077 4 638 648 747 924
national FR940405-1-00077 3 644 857 978
interview FR940405-1-00077 2 646 980
survey FR940405-1-00077 2 647 981
primary FR940405-1-00077 1 650
source FR940405-1-00077 2 652 746
us FR940405-1-00077 2 654 1034
population FR940405-1-00077 2 655 701
frequency FR940405-1-00077 4 656 677 696 719
rates FR940405-1-00077 4 657 678 697 703
acute FR940405-1-00077 3 659 671 1090
other FR940405-1-00077 2 663 682
common FR940405-1-00077 1 666
cold FR940405-1-00077 1 667
influenza FR940405-1-00077 1 669
bronchitis FR940405-1-00077 1 672
pneumonia FR940405-1-00077 1 675
severe FR940405-1-00077 5 680 709 990 1071 1168
headaches FR940405-1-00077 8 681 710 907 923 991 1072 1151 1164
migraines FR940405-1-00077 1 684
reported FR940405-1-00077 4 695 856 898 925
representative FR940405-1-00077 2 699 758
comment FR940405-1-00077 3 714 1177 1204
use FR940405-1-00077 1 717
place FR940405-1-00077 1 722
observed FR940405-1-00077 2 727 961
relative FR940405-1-00077 6 728 828 899 919 949 962
risks FR940405-1-00077 4 729 829 900 950
comparable FR940405-1-00077 2 731 852
4219 FR940405-1-00077 1 740
california FR940405-1-00077 2 749 767
healthy FR940405-1-00077 1 750
study FR940405-1-00077 6 752 755 821 864 1121 1184
surveyed FR940405-1-00077 1 756
sample FR940405-1-00077 2 759 795
12 FR940405-1-00077 1 761
public FR940405-1-00077 1 762
northern FR940405-1-00077 1 766
ascertain FR940405-1-00077 1 769
airconditioned FR940405-1-00077 7 777 909 1075 1123 1136 1155 1190
either FR940405-1-00077 1 784
smokefree FR940405-1-00077 1 785
separately FR940405-1-00077 1 788
ventilated FR940405-1-00077 2 789 915
designated FR940405-1-00077 1 790
smoking FR940405-1-00077 1 791
areas FR940405-1-00077 1 792
included FR940405-1-00077 2 796 822
6 FR940405-1-00077 1 797
air- FR940405-1-00077 1 800
systems FR940405-1-00077 1 802
3 FR940405-1-00077 2 804 814
mechanical FR940405-1-00077 1 807
880 FR940405-1-00077 1 823
several FR940405-1-00077 1 831
subset FR940405-1-00077 1 837
these FR940405-1-00077 1 839
shown FR940405-1-00077 2 842 1110
iv11 FR940405-1-00077 1 845
effort FR940405-1-00077 1 849
define FR940405-1-00077 1 851
between FR940405-1-00077 1 854
statistics FR940405-1-00077 1 858
nhis FR940405-1-00077 1 860
computational FR940405-1-00077 1 867
ease FR940405-1-00077 1 868
grouped FR940405-1-00077 1 870
runny FR940405-1-00077 2 872 942
nose FR940405-1-00077 4 873 878 938 943
stuffy FR940405-1-00077 2 877 937
dry/irritated FR940405-1-00077 1 882
throat FR940405-1-00077 1 883
dry/irritated/itching FR940405-1-00077 1 888
eyes FR940405-1-00077 1 889
frequent FR940405-1-00077 2 906 922
naturally FR940405-1-00077 1 914
1.5. FR940405-1-00077 1 928
etc. FR940405-1-00077 1 946
ranged FR940405-1-00077 1 951
1.4 FR940405-1-00077 2 953 958
1.8. FR940405-1-00077 1 955
cdc FR940405-1-00077 1 969
current FR940405-1-00077 1 974
1992 FR940405-1-00077 1 983
rate FR940405-1-00077 2 988 1008
requiring FR940405-1-00077 1 993
attention FR940405-1-00077 1 995
activity FR940405-1-00077 2 997 1173
restriction FR940405-1-00077 1 998
least FR940405-1-00077 2 1002 1015
5 FR940405-1-00077 1 1003
thousand FR940405-1-00077 4 1005 1018 1082 1098
9 FR940405-1-00077 1 1016
addition FR940405-1-00077 2 1021 1200
70 FR940405-1-00077 1 1038
percent FR940405-1-00077 1 1039
see FR940405-1-00077 1 1041
regulatory FR940405-1-00077 1 1043
impact FR940405-1-00077 1 1044
section FR940405-1-00077 2 1046 1060
above FR940405-1-00077 1 1051
ivd FR940405-1-00077 1 1061
lifetime FR940405-1-00077 3 1067 1087 1212
burden FR940405-1-00077 1 1069
experienced FR940405-1-00077 1 1073
57 FR940405-1-00077 1 1079
employees FR940405-1-00077 2 1084 1100
85 FR940405-1-00077 1 1095
iv12 FR940405-1-00077 1 1113
derived FR940405-1-00077 1 1118
make FR940405-1-00077 1 1127
implicit FR940405-1-00077 1 1144
assumption FR940405-1-00077 1 1145
increase FR940405-1-00077 1 1148
environment FR940405-1-00077 1 1157
occurs FR940405-1-00077 1 1158
enough FR940405-1-00077 1 1169
affect FR940405-1-00077 1 1171
work FR940405-1-00077 1 1172
applicability FR940405-1-00077 1 1180
due FR940405-1-00077 1 1192
its FR940405-1-00077 1 1206
developing FR940405-1-00077 1 1209
attributable FR940405-1-00077 1 1215
exposures FR940405-1-00077 1 1218
table FR940405-1-00078 1 0
iv FR940405-1-00078 1 1
11._ FR940405-1-00078 1 2
california FR940405-1-00078 1 3
healthy FR940405-1-00078 1 4
building FR940405-1-00078 1 5
study FR940405-1-00078 1 6
comparing FR940405-1-00078 1 7
buildings FR940405-1-00078 2 8 13
with FR940405-1-00078 2 9 14
natural FR940405-1-00078 1 10
ventilation FR940405-1-00078 1 11
to FR940405-1-00078 1 12
airconditioning1 FR940405-1-00078 1 15
1health FR940405-1-00078 1 16
outcome FR940405-1-00078 1 17
1relative FR940405-1-00078 1 18
risk FR940405-1-00078 1 19
1confidence FR940405-1-00078 1 20
interval FR940405-1-00078 1 21
upper FR940405-1-00078 1 22
respiratory FR940405-1-00078 1 23
symptoms FR940405-1-00078 1 24
: FR940405-1-00078 1 25
runny FR940405-1-00078 1 26
nose FR940405-1-00078 2 27 33
1.5 FR940405-1-00078 1 28
( FR940405-1-00078 2 29 35
0.92.5 FR940405-1-00078 1 30
) FR940405-1-00078 2 31 37
stuffy FR940405-1-00078 1 32
1.8 FR940405-1-00078 1 34
1.23.7 FR940405-1-00078 1 36
dry/irritated FR940405-1-00078 1 38
throat FR940405-1-00078 1 39
1.6 FR940405-1-00078 1 40
